|
Cyclo(-Gly-Arg-Gly-Asp-Ser-Pro-Ala)
|
|
128857-77-2
|
|
Eptifibatide
|
|
188627-80-7
|
|
Cyclo(-Arg-Ala-Asp-D-Tyr-Lys)
|
|
1193347-53-3
|
|
Fibronectin CS-1 Fragment (1978-1982)
|
|
150525-67-0
|
|
Exendin-4 (1-8)
|
|
1802078-29-0
|
|
Exendin-4 (3-39)
|
|
196109-31-6
|
|
Exendin (9-39)
|
|
133514-43-9
|
|
(Glu8.9)-Helodermin
|
|
209340-47-6
|
|
PEG30K-Cys-AEEAc-Fibrinopeptide A (1-15)
|
|
|
|
(Tyr0)-Fibrinopeptide A (human)
|
|
103226-11-5
|
|
Fibrinopeptide B (human)
|
|
36204-23-6
|
|
(Glu1)-Fibrinopeptide B (human)
|
|
103213-49-6
|
|
(Tyr15)-Fibrinopeptide B (human)
|
|
125455-56-3
|
|
Ac-Asp-Arg-Leu-Asp-Ser-OH
|
|
153959-57-0
|
|
H-Gly-Arg-Ala-Asp-Ser-Pro-OH
|
|
99896-86-3
|
|
Fibronectin Fragment (1954-1959)
|
|
184895-13-4
|
|
Fibronectin Fragment (1377-1388)
|
|
162257-99-0
|
|
Galacto-RGD
|
|
922175-70-0
|
|
H-Gly-Arg-Ala-Asp-Ser-Pro-Lys-OH
|
|
125455-58-5
|
|
H-Gly-Arg-Gly-Asp-OH
|
|
97461-81-9
|
|
Biotinyl-εAhx-Gly-Arg-Gly-Asp-Ser-OH
|
|
2022956-45-0
|
|
H-Gly-Arg-Gly-Asp-Ser-Cys-OH
|
|
91037-71-7
|
|
H-Gly-Arg-Gly-Asp-Ser-Pro-OH
|
|
91037-75-1
|
|
Ac-Pen-Arg-Gly-Asp-Cys-OH (Disulfide bond)
|
|
135702-36-2
|
|
H-Arg-Gly-Asp-OH
|
|
99896-85-2
|
|
H-Arg-Gly-Asp-Ser-OH
|
|
91037-65-9
|
|
H-Arg-Gly-Asp-Ser-Pro-OH
|
|
110697-44-4
|
|
H-D-Arg-Gly-Asp-Trp-OH
|
|
144161-76-2
|
|
H-Arg-Gly-Asp-Val-OH
|
|
93674-99-8
|
|
H-Arg-Gly-Glu-OH
|
|
20274-91-3
|
|
H-Arg-Phe-Asp-Ser-OH
|
|
102567-19-1
|
|
Bifunctional Antiplatelet Agent
|
|
148796-92-3
|
|
Cilengitide
|
|
188968-51-6
|
|
Cyclo(-Ala-Arg-Gly-Asp-3-aminomethylbenzoyl)
|
|
153381-95-4
|
|
Cyclo(-Arg-Ala-Asp-D-Phe-Cys)
|
|
1055991-02-0
|
|
Cyclo(-Arg-Ala-Asp-D-Phe-Lys)
|
|
756500-23-9
|
|
Cyclo(-Arg-Gly-Asp-D-Phe-Glu)
|
|
756500-22-8
|
|
Cyclo(-Arg-Gly-Asp-D-Tyr-Lys)
|
|
217099-14-4
|
|
Cyclo(-Gly-Arg-Gly-Glu-Ser-Pro)
|
|
2022956-43-8
|
|
H-Cys-Gln-Asp-Ser-Glu-Thr-Arg-Thr-Phe-Tyr-OH
|
|
94040-53-6
|
|
Fibronectin Adhesion-Promoting Peptide
|
|
125720-21-0
|
|
(4-((2-Methylphenyl)aminocarbonyl)-aminophenyl)acetyl-Fibronectin CS-1 Fragment (1980-1983)
|
|
187735-94-0
|
|
Fibronectin Fragment (1376-1380)
|
|
158622-13-0
|
|
FITC-εAhx-Gly-Arg-Gly-Asp-Ser-Pro-OH
|
|
2022956-44-9
|
|
Cyclo(-Arg-Gly-Asp-D-Phe-Cys)
|
|
862772-11-0
|
|
Cyclo(-Arg-Gly-Asp-D-Phe-Lys)
|
|
161552-03-0
|
|
H-Gly-Arg-Gly-Asp-D-Ser-Pro-OH
|
|
111844-24-7
|
|
H-Gly-Arg-Gly-Asp-Ser-Pro-Cys-OH
|
|
91575-26-7
|
|
H-Gly-Arg-Gly-Asp-Ser-Pro-Lys-OH
|
|
111119-28-9
|
|
H-Gly-Arg-Gly-Asp-Thr-Pro-OH
|
|
108682-58-2
|
|
H-Gly-Arg-Gly-Glu-Ser-OH
|
|
97461-84-2
|
|
H-Gly-Arg-Gly-Glu-Ser-Pro-OH
|
|
99896-88-5
|
|
H-Gly-Pen-Gly-Arg-Gly-Asp-Ser-Pro-Cys-Ala-OH (Disulfide bond between Pen2 and Cys)
|
|
126716-28-7
|
|
H-Gly-Phe-Arg-Gly-Asp-Gly-Gln-OH
|
|
148913-98-8
|
|
Integrin Binding Peptide
|
|
278792-07-7
|
|
H-Lys-Asn-Asn-Gln-Lys-Ser-Glu-Pro-Leu-Ile-Gly-Arg-Lys-Lys-Thr-OH
|
|
111793-75-0
|
|
H-Lys-Gln-Ala-Gly-Asp-Val-OH
|
|
80755-87-9
|
|
H-Lys-Gly-Asp-Ser-OH
|
|
93674-95-4
|
|
H-Lys-Gly-Glu-OH
|
|
88096-12-2
|
|
Phenylac-Leu-Asp-Phe-D-Pro-NH2
|
|
209601-16-1
|
|
H-Pro-Ser-Hyp-Gly-Asp-Trp-OH
|
|
163722-91-6
|
|
RGD-4C
|
|
332179-76-7
|
|
RGD Negative Control
|
|
756500-24-0
|
|
H-Ser-Asp-Gly-Arg-Gly-OH
|
|
108608-63-5
|
|
H-Tyr-Arg-Gly-Asp-Ser-OH
|
|
134282-68-1
|
|
Fmoc-Ala-Ala-OH
|
|
87512-31-0
|
|
Fmoc-Gly-Gly-Gly-OH
|
|
170941-79-4
|
|
Fmoc-Gly-Phe-OH
|
|
117370-45-3
|
|
Fmoc-Gly-Pro-Hyp-OH
|
|
185213-75-6
|
|
Fmoc-Gly-Val-OH
|
|
86895-14-9
|
|
Fmoc-Nle-Nle-OH
|
|
251316-91-3
|
|
Fmoc-Phe-Arg-OH
|
|
250695-64-8
|
|
Fmoc-Phe-Phe-OH
|
|
84889-09-8
|
|
Fmoc-Phe-Ser(tBu)-OH
|
|
157675-78-0
|
|
Fmoc-Pro-Phe-OH
|
|
120943-07-9
|
|
Fmoc-Pro-Pro-Pro-OH
|
|
134303-96-1
|
|
Fmoc-Pro-Pro-Pro-Pro-OH
|
|
454693-96-0
|
|
Fmoc-D-Pro-D-Pro-D-Pro-D-Pro-OH
|
|
1926163-34-9
|
|
Fibrinopeptide A (human)
|
|
25422-31-5
|
|
Helodermin
|
|
89468-62-2
|
|
Exendin-3
|
|
130357-25-4
|
|
(Glu9)-Exenatide (2-39)
|
|
196109-34-9
|
|
Echistatin
|
|
154303-05-6
|
|
Cyclo(-D-Tyr-Arg-Gly-Asp-Cys(carboxymethyl)-OH) sulfoxide
|
|
143120-27-8
|
|
Fibronectin CS-1 Fragment (1978-1985)
|
|
136466-51-8
|
|
H-Cys-Arg-Gly-Asp-Phe-Pro-Ala-Ser-Ser-Cys-OH (Disulfide bond)
|
|
166184-23-2
|
|
Met(O)14-Exenatide
|
|
1678417-38-3
|
|
RGD-targeted Proapoptotic Peptide
|
|
|
|
Cyclo(-Arg-Ala-Asp-D-Phe-Val)
|
|
137813-36-6
|
|
H-Asp-Arg-Gly-Asp-Ser-OH
|
|
151997-53-4
|
|
H-Arg-Gly-Glu-Ser-OH
|
|
93674-97-6
|
|
H-Arg-Gly-Asp-Ser-Pro-Ala-Ser-Ser-Lys-Pro-OH
|
|
91575-25-6
|
|
H-Arg-Gly-Asp-Cys-OH
|
|
109292-46-8
|
|
H-Gly-Arg-Gly-Asp-Ser-NH2
|
|
143648-02-6
|
|
H-Gly-Arg-Gly-Asp-Ser-OH
|
|
96426-21-0
|
|
H-Gly-Arg-Gly-Asp-Asn-Pro-OH
|
|
114681-65-1
|
|
H-Glu[cyclo(-Arg-Gly-Asp-D-Phe-Lys)]-cyclo(-Arg-Gly-Asp-D-Phe-Lys)
|
|
250612-47-6
|
|
Fibronectin Fragment (196-203)
|
|
150525-72-7
|
|
Cyclo(-Gly-Arg-Gly-Asp-Ser-Pro)
|
|
135432-37-0
|
|
Cyclo(-Arg-Gly-Asp-D-Phe-Val)
|
|
137813-35-5
|